Combined use of acid fibroblast growth factor, granulocyte colony-stimulating factor and zinc sulphate accelerates diabetic ulcer healing

Journal of Health Science

Volumn 55, Issue 6, 2009, Pages 910-922

  Lin, Shaoqiang ^a   Xu, Hengwu ^a   Xiao, Jian ^a   Liu, Yanlong ^a   Zhang, Yi ^a   Cai, Lu ^a,b   Li, Xiaokun ^a   Tan, Yi ^a,b  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b University of Louisville School of Medicine   (United States)

Author keywords

Acid fibroblast growth factor; Diabetic ulcer; Granulocyte colony stimulating factor; Zinc

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR; INSULIN; INTERSTITIAL COLLAGENASE; RECOMBINANT HUMAN ACID FIBROBLAST GROWTH FACTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG; ZINC SULFATE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAPILLARY DENSITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DIABETES MELLITUS; DOWN REGULATION; EPIDERMIS CELL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SINGLE DRUG DOSE; SKIN INJURY; ULCER HEALING; UPREGULATION; WOUND HEALING IMPAIRMENT;

RATTUS;

EID: 74549173655     PISSN: 13449702     EISSN: 13475207     Source Type: Journal    
DOI: 10.1248/jhs.55.910     Document Type: Article

References (57)

1. Brem, H. and Tomic-Canic, M. (2007) Cellular and molecular basis of wound healing in diabetes. J. Clin. Invest., 117, 1219-1222.
2. Pavlovic, M. D., Milenkovic, T., Dinic, M., Misovic, M., Dakovic, D., Todorovic, S., Dakovic, Z., Zecevi, R. D. and Doder, R. (2007) The prevalence of cutaneous manifestations in young patients with type 1 diabetes. Diabetes Care, 30, 1964-1967.
3. Blakytny, R. and Jude, E. (2006) The molecular biology of chronic wounds and delayed healing in diabetes. Diabet. Med., 23, 594-608.
4. Blakytny, R., Jude, E. B., Martin Gibson, J., Boulton, A. J. and Ferguson, M. W. (2000) Lack of insulin-like growth factor 1 (IGF1) in the basal keratinocyte layer of diabetic skin and diabetic foot ulcers. J. Pathol., 190, 589-594.
5. Jude, E. B., Blakytny, R., Bulmer, J., Boulton, A. J. and Ferguson, M. W. (2002) Transforming growth factor-beta 1, 2, 3 and receptor type I and II in diabetic foot ulcers. Diabet. Med., 19, 440-447.
6. Brownlee, M. (2001) Biochemistry and molecular cell biology of diabetic complications. Nature, 414, 813-820.
7. Sowers, J. R. and Stump, C. S. (2004) Insights into the biology of diabetic vascular disease: what's new? Am. J. Hypertens, 17, 2S-6S.
8. Inoue, M., Ono, I., Tateshita, T., Kuroyanagi, Y. and Shioya, N. (1998) Effect of a collagen matrix containing epidermal growth factor on wound contraction. Wound Repair Regen., 6, 213-222.
9. Lee, A. R. (2005) Enhancing dermal matrix regeneration and biomechanical properties of 2nd degree-burn wounds by EGF-impregnated collagen sponge dressing. Arch. Pharm. Res., 28, 1311-1316.
10. Cheng, B., Liu, H. W., Fu, X. B., Sun, T. Z. and Sheng, Z. Y. (2007) Recombinant human platelet-derived growth factor enhanced dermal wound healing by a pathway involving ERK and c-fos in diabetic rats. J. Dermatol. Sci., 45, 193-201.
11. Eldor, R., Raz, I., Ben Yehuda, A. and Boulton, A. J. (2004) New and experimental approaches to treatment of diabetic foot ulcers: a comprehensive review of emerging treatment strategies. Diabet. Med., 21, 1161-1173.
12. Duraisamy, Y., Slevin, M., Smith, N., Bailey, J., Zweit, J., Smith, C., Ahmed, N. and Gaffney, J. (2001) Effect of glycation on basic fibroblast growth factor induced angiogenesis and activation of associated signal transduction pathways in vascular endothelial cells: possible relevance to wound healing in diabetes. Angiogenesis, 4, 277-288.
13. Kloth, L. C. and Mcculloch, J. M. (2002) Wound Healing Alternatives in Management, FA Davis Company, Philadephia.
14. Muangman, P., Muffley, L. A., Anthony, J. P., Spenny, M. L., Underwood, R. A., Olerud, J. E. and Gibran, N. S. (2004) Nerve growth factor accelerates wound healing in diabetic mice. Wound Repair Regen., 12, 44-52.
15. Galiano, R. D., Tepper, O. M., Pelo, C. R., Bhatt, K. A., Callaghan, M., Bastidas, N., Bunting, S., Steinmetz, H. G. and Gurtner, G. C. (2004) Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am. J. Pathol., 164, 1935-1947.
16. Matuszewska, B., Keogan, M., Fisher, D. M., Soper, K. A., Hoe, C. M., Huber, A. C. and Bondi, J. V. (1994) Acidic fibroblast growth factor: evaluation of topical formulations in a diabetic mouse wound healing model. Pharm. Res., 11, 65-71.
17. Tsuboi, R. and Rifkin, D. B. (1990) Recombinant basic fibroblast growth factor stimulates wound healing in healing-impaired db/db mice. J. Exp. Med., 172, 245-251.
18. Ito, K., Ito, S., Sekine, M. and Abe, M. (2005) Reconstruction of the soft tissue of a deep diabetic foot wound with artificial dermis and recombinant basic fibroblast growth factor. Plast. Reconstr. Surg., 115, 567-572.
19. Tan, Y., Xiao, J., Huang, Z., Xiao, Y., Lin, S., Jin, L., Feng, W., Cai, L. and Li, X. (2008) Comparison of the therapeutic effects between recombinant human acidic and basic fibroblast growth factors in wound healing in diabetic patients. J. Health Sci., 54, 423-440.
20. Song, Y., Wang, J., Li, X. K. and Cai, L. (2005) Zinc and the diabetic heart. Biometals, 18, 325-332.
21. Mata, A. D., Marques, D., Rocha, S., Francisco, H., Santos, C., Mesquita, M. F. and Singh, J. (2004) Effects of diabetes mellitus on salivary secretion and its composition in the human. Mol. Cell. Biochem., 261, 137-142.
22. Bouda, M., Krizek, M., Malkusova, I., Motan, J., Pizinger, K. and Rusavy, Z. (1994) Zinc deficiency as a cause of dermatosis in a patient with type I diabetes and renal insufficiency. Vnitr. Lek., 40, 445-447.
23. Agren, M. S., Soderberg, T. A., Reuterving, C. O., Hallmans, G. and Tengrup, I. (1991) Effect of topical zinc oxide on bacterial growth and inflammation in full-thickness skin wounds in normal and diabetic rats. Eur. J. Surg., 157, 97-101.
24. Rostan, E. F., Debuys, H. V., Madey, D. L. and Pinnell, S. R. (2002) Evidence supporting zinc as an important antioxidant for skin. Int. J. Dermatol., 41, 606-611.
25. Lansdown, A. B. (2002) Metallothioneins: potential therapeutic aids for wound healing in the skin. Wound Repair Regen., 10, 130-132.
26. Loomans, C. J., De Koning, E. J., Staal, F. J., Rookmaaker, M. B., Verseyden, C., De Boer, H. C., Verhaar, M. C., Braam, B., Rabelink, T. J. and Van Zonneveld, A. J. (2004) Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes, 53, 195-199.
27. Kaji, T., Fujiwara, Y., Yamamoto, C., Sakamoto, M. and Kozuka, H. (1994) Stimulation by zinc of cultured vascular endothelial cell proliferation: possible involvement of endogenous basic fibroblast growth factor. Life Sci., 55, 1781-1787.
28. Fujiwara, Y. and Kaji, T. (1997) Zinc potentiates the stimulation by basic and acidic fibroblast growth factors on the proliferation of cultured vascular smooth muscle cells. Res. Commun. Mol. Pathol. Pharmacol., 97, 95-106.
29. Sivan-Loukianova, E., Awad, O. A., Stepanovic, V., Bickenbach, J. and Schatteman, G. C. (2003) CD34+ blood cells accelerate vascularization and healing of diabetic mouse skin wounds. J. Vasc. Res., 40, 368-377.
30. Fang, B., Shi, M., Liao, L., Yang, S., Liu, Y. and Zhao, R. C. (2003) Multiorgan engraftment and multilineage differentiation by human fetal bone marrow Flk1+/CD31-/CD34- Progenitors. J. Hematother. Stem Cell Res., 12, 603-613.
31. Canturk, N. Z., Vural, B., Esen, N., Canturk, Z., Oktay, G., Kirkali, G. and Solakoglu, S. (1999) Effects of granulocyte-macrophage colony-stimulating factor on incisional wound healing in an experimental diabetic rat model. Endocr. Res., 25, 105-116.
32. Groves, R. W. and Schmidt-Lucke, J. A. (2000) Recombinant human GM-CSF in the treatment of poorly healing wounds. Adv. Skin Wound Care, 13, 107-112.
33. Mery, L., Girot, R. and Aractingi, S. (2004) Topical effectiveness of molgramostim (GM-CSF) in sickle cell leg ulcers. Dermatology, 208, 135-137.
34. Albertson, S., Hummel, R. P., 3rd., Breeden, M. and Greenhalgh, D. G. (1993) PDGF and FGF reverse the healing impairment in protein-malnourished diabetic mice. Surgery, 114, 368-372; discussion 372-363.
35. Greenhalgh, D. G., Sprugel, K. H., Murray, M. J. and Ross, R. (1990) PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am. J. Pathol., 136, 1235-1246.
36. Brown, R. L., Breeden, M. P. and Greenhalgh, D. G. (1994) PDGF and TGF-alpha act synergistically to improve wound healing in the genetically diabetic mouse. J. Surg. Res., 56, 562-570.
37. Kiritsy, C. P., Antoniades, H. N., Carlson, M. R., Beaulieu, M. T., D'andrea, M. and Lynch, S. E. (1995) Combination of platelet-derived growth factor-BB and insulin-like growth factor-I is more effective than platelet-derived growth factor-BB alone in stimulating complete healing of full-thickness wounds in "older" diabetic mice. Wound Repair Regen., 3, 340-350.
38. Wang, W., Lin, S., Xiao, Y., Huang, Y., Tan, Y., Cai, L. and Li, X. (2008) Acceleration of diabetic wound healing with chitosan-crosslinked collagen sponge containing recombinant human acidic fibroblast growth factor in healing-impaired STZ diabetic rats. Life Sci., 82, 190-204.
39. Fredj-Reygrobellet, D., Plouet, J., Delayre, T., Baudouin, C., Bourret, F. and Lapalus, P. (1987) Effects of aFGF and bFGF on wound healing in rabbit corneas. Curr. Eye Res., 6, 1205-1209.
40. Lansdown, A. B., Mirastschijski, U., Stubbs, N., Scanlon, E. and Agren, M. S. (2007) Zinc in wound healing: theoretical, experimental, and clinical aspects. Wound Repair Regen., 15, 2-16.
41. Zhang, X. J., Wu, X., Wolf, S. E., Hawkins, H. K., Chinkes, D. L. and Wolfe, R. R. (2007) Local insulin-zinc injection accelerates skin donor site wound healing. J. Surg. Res., 142, 90-96.
42. Norman, J. N., Rahmat, A. and Smith, G. (1975) Effect of supplements of zinc salts on the healing of granulating wounds in the rat and guinea pig. J. Nutr., 105, 815-821.
43. Cavanagh, P. R., Lipsky, B. A., Bradbury, A. W. and Botek, G. (2005) Treatment for diabetic foot ulcers. Lancet, 366, 1725-1735.
44. Cullen, B. (2002) The role of oxidized regenerated cellulose/collagen in chronic wound repair. Part 2. Ostomy Wound Manage., 48, 8-13.
45. Neely, A. N., Clendening, C. E., Gardner, J. and Greenhalgh, D. G. (2000) Gelatinase activities in wounds of healing-impaired mice versus wounds of non-healing-impaired mice. J. Burn. Care Rehabil., 21, 395-402.
46. Armstrong, D. G. and Jude, E. B. (2002) The role of matrix metalloproteinases in wound healing. J. Am. Podiatr. Med. Assoc., 92, 12-18.
47. Mi, Q., Riviere, B., Clermont, G., Steed, D. L. and Vodovotz, Y. (2007) Agent-based model of inflammation and wound healing: insights into diabetic foot ulcer pathology and the role of transforming growth factor-beta1. Wound Repair Regen., 15, 671-682.
48. Krishnan, S. T., Baker, N. R., Carrington, A. L. and Rayman, G. (2004) Comparative roles of microvascular and nerve function in foot ulceration in type 2 diabetes. Diabetes Care, 27, 1343-1348.
49. Medina, A., Scott, P. G., Ghahary, A. and Tredget, E. E. (2005) Pathophysiology of chronic nonhealing wounds. J. Burn. Care Rehabil., 26, 306-319.
50. Li, X. K., Lin, Z. F., Li, Y., Hu, S., Tan, Y., Huang, Z., Meng, J., Liang, L. M., Xiao, J., Qu, J. and Cai, L. (2007) Cardiovascular protection of nonmitogenic human acidic fibroblast growth factor from oxidative damage in vitro and in vivo. Cardiovasc. Pathol., 16, 85-91.
51. Lopez, J. J., Edelman, E. R., Stamler, A., Hibberd, M. G., Prasad, P., Thomas, K. A., Disalvo, J., Caputo, R. P., Carrozza, J. P., Douglas, P. S., Sellke, F. W. and Simons, M. (1998) Angiogenic potential of perivascularly delivered aFGF in a porcine model of chronic myocardial ischemia. Am. J. Physiol., 274, H930-H936.
52. Hinchliffe, R. J., Valk, G. D., Apelqvist, J., Armstrong, D. G., Bakker, K., Game, F. L., Hartemann-Heurtier, A., Londahl, M., Price, P. E., Van Houtum, W. H. and Jeffcoate, W. J. (2008) A systematic review of the effectiveness of interventions to enhance the healing of chronic ulcers of the foot in diabetes. Diabetes Metab. Res. Rev., 24(Suppl 1), S119-S144.
53. Ovington, L. G. (2002) Overview of matrix metalloprotease modulation and growth factor protection in wound healing. Part 1. Ostomy Wound Manage., 48, 3-7.
54. Schwartz, J. R., Marsh, R. G. and Draelos, Z. D. (2005) Zinc and skin health: overview of physiology and pharmacology. Dermatol. Surg., 31, 837-847.
55. Nwomeh, B. C., Liang, H. X., Cohen, I. K. and Yager, D. R. (1999) MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers. J. Surg. Res., 81, 189-195.
56. Schlienger, J. L., Grunenberger, F., Maier, E. A., Simon, C., Chabrier, G. and Leroy, M. J. (1988) Disorders of plasma trace elements in diabetes. Relation to blood glucose equilibrium. Presse Med., 17, 1076-1079.
57. Mateo, M. C., Bustamante, J. B. and Cantalapiedra, M. A. (1978) Serum, zinc, copper and insulin in diabetes mellitus. Biomedicine, 29, 56-58.